Barclays Raises Natera (NASDAQ:NTRA) Price Target to $190.00
Natera (NASDAQ:NTRA – Get Free Report) had its price target boosted by research analysts at Barclays from $160.00 to $190.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has an “overweight” rating on the medical research company’s stock. Barclays‘s price target points to a potential upside of 25.84% […]
Natera (NASDAQ:NTRA – Get Free Report) had its price target boosted by research analysts at Barclays from $160.00 to $190.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has an “overweight” rating on the medical research company’s stock. Barclays‘s price target points to a potential upside of 25.84% […]
